Practical Bayesian Guidelines for Phase IIB Clinical Trials
From MaRDI portal
Publication:4842831
DOI10.2307/2533377zbMath0821.62090OpenAlexW2007648830WikidataQ52376624 ScholiaQ52376624MaRDI QIDQ4842831
Peter F. Thall, Richard M. Simon
Publication date: 3 October 1995
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.2307/2533377
Applications of statistics to biology and medical sciences; meta analysis (62P10) Bayesian problems; characterization of Bayes procedures (62C10) Sequential statistical design (62L05)
Related Items
Designs for Single- or Multiple-Agent Phase I Trials, Novel Bayesian Adaptive Designs and Their Applications in Cancer Clinical Trials, On a Type of Probability Stopping Rule for Toxicity Study, Generalized Likelihood Ratio Statistics and Uncertainty Adjustments in Efficient Adaptive Design of Clinical Trials, Bayesian Optimal Design for Phase II Screening Trials, Bayesian predictive monitoring with bivariate binary outcomes in phase II clinical trials, Control of type I error rates in Bayesian sequential designs, Decision Theoretic Designs for Phase II Clinical Trials with Multiple Outcomes, A hybrid Bayesian-frequentist predictive design for monitoring multi-stage clinical trials, A Bayesian Decision Approach for Sample Size Determination in Phase II Trials, Decision-Theoretic Designs for Pre-Phase II Screening Trials in Oncology, Monitoring the Rates of Composite Events with Censored Data in Phase II Clinical Trials, Decision-Theoretic Designs for Phase II Clinical Trials Allowing for Competing Studies, Efficacy and toxicity monitoring via Bayesian predictive probabilities in phase II clinical trials, A review of phase 2-3 clinical trial designs, Testing simultaneous hypotheses in pharmaceutical trials: a bayesian approach, MULTINOMIAL PHASE II CANCER TRIALS INCORPORATING RESPONSE AND EARLY PROGRESSION, An Introduction to Practical Sequential Inferences via Single-Arm Binary Response Studies Using the binseqtest R Package
